E Oosterwijk
机构: associate professor Radboudumc
每年引用次数
引用次数
引用: 16,066
H-指数: 66
I10-指数 : 221
出版物: 565
ImmunoPET imaging of renal cell carcinoma with 124I- and 89Zr-labeled anti-CAIX monoclonal antibody cG250
Alexander Stillebroer , Gerben Franssen , Wim Oyen , Egbert Oosterwijk
Society of Nuclear Medicine Annual Meeting Abstracts 51 500
2010
Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients
Stijn Muselaers , Otto Boerman , Alexander Stillebroer , Ingrid Desar
The Journal of Nuclear Medicine 53 27 -27
1
2012
Monoclonal Antibodies in Advanced Renal Cell Carcinoma
Egbert Oosterwijk , Chetan R. Divgi , Martijn S. Steffens , Neil H. Bander
Humana Press, Totowa, NJ 343 -358
2000
Monitoring Lutetium-177-anti-CAIX radioimmunotherapy with In-111-anti-CAIX SPECT in an intraperitoneal clear cell renal cell carcinoma xenograft model
Constantijn Muselaers , Desiree Bos , Peter Mulders , Egbert Oosterwijk
The Journal of Nuclear Medicine 54 116 -116
2013
Effect of sorafenib on imaging of clear cell renal cell carcinoma using 111-Indium labeled bevacizumab
Alexander Stillebroer , Otto Boerman , Egbert Oosterwijk , Peter Mulders
Society of Nuclear Medicine Annual Meeting Abstracts 49
2008
Radioimmunotherapy with Lutetium-177 labeled monoclonal antibody cG250 in patients with advanced renal cell carcinoma
Alexander Stillebroer , Otto Boerman , Egbert Oosterwijk , Peter Mulders
Society of Nuclear Medicine Annual Meeting Abstracts 49
3
2008
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
Egbert Oosterwijk , Frank G. van Schaijk , Frans H. M. Corstens , Wim J. G. Oyen
Clinical Cancer Research 9 ( 10)
11
2003
Correspondence re: Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, D. Carey, and D. T. Curiel, Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002.
Egbert Oosterwijk , Dorien M. Tiemessen , Peter F. A. Mulders , Wim Jongmans
Cancer Research 63 ( 8) 1994 -1995
1
2003
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
Egbert Oosterwijk , Annemieke C. Soede , Frank G. van Schaijk , Frans H.M. Corstens
The Journal of Nuclear Medicine 46 ( 3) 495 -501
39
2005
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
Egbert Oosterwijk , Frans H. M. Corstens , Wim J. G. Oyen , Wilhelmina C. A. M. Buijs
Clinical Cancer Research 9 ( 10)
56
2003
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Egbert Oosterwijk , Frans H. M. Corstens , Wim J. G. Oyen , Jeannette Oosterwijk-Wakka
Cancer Research 59 ( 17) 4400 -4405
85
1999
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
George Sgouros , Chaitanya R. Divgi , Joseph A. O'Donoghue , Devie Deland
Clinical Cancer Research 4 ( 11) 2729 -2739
150
1998
Complex Cadherin Expression in Renal Cell Carcinoma
Laurence A. Giroldi , Egbert Oosterwijk , Jack A. Schalken , Toru Shimazui
Cancer Research 56 ( 14) 3234 -3237
81
1996
Residualizing Iodine Markedly Improved Tumor Targeting Using Bispecific Antibody-Based Pretargeting
Egbert Oosterwijk , Frank G. van Schaijk , Frans H.M. Corstens , David M. Goldenberg
The Journal of Nuclear Medicine 46 ( 6) 1016 -1022
22
2005
Radioimmunotherapy with Lu-177 labeled anti-CAIX monoclonal antibody in advanced renal cell carcinoma
Alexander Stillebroer , Otto Boerman , Peter Mulders , Ingrid Desar
The Journal of Nuclear Medicine 52 359 -359
2011
Colocalization of Carbonic Anhydrase 9 Expression and Cell Proliferation in Human Head and Neck Squamous Cell Carcinoma
Johannes H A M Kaanders , Egbert Oosterwijk , Albert J van der Kogel , Henri A M Marres
Clinical Cancer Research 11 ( 1) 97 -106
70
2005
The expression of G250/MN/CA9 antigen by flow cytometry : Its possible implication for detection of micrometastatic renal cancer cells
Karine Passebosc-Faure , Egbert Oosterwijk , Christian Genin , Guorong Li
Clinical Cancer Research 7 ( 1) 89 -92
50
2001
Ex vivo perfusion of tumorous kidneys with a dual-modality imaging probe
Egbert Oosterwijk , Mark Rijpkema , Marlène Hekman , Desirée Bos
The Journal of Nuclear Medicine 56 1209 -1209
1
2015
Radionuclide and fluorescence imaging of renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody G250
Constantijn Muselaers , Mark Rijpkema , Desiree Bos , Johan Langenhuijsen
Society of Nuclear Medicine Annual Meeting Abstracts 55 66
2014
Renal cell carcinoma-antigen G250-derived peptides that elicit both CD4+ and CD8+ T-cell responses
Joost Vissers , Ingrid De Vries , Egbert Oosterwijk , Carl Figdor
1
2004